Fellowship · Philadelphia, PA
Sponsored by University of Pennsylvania Health System
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Robert Giuntoli
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Robert Giuntoli
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 587 citations · Heidi Gray, Emese Zsiros
A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance.
Nature immunology · 2022 · 482 citations · Alexander Huang
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 346 citations · Heidi Gray, Emese Zsiros
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 358 citations · Mark Morgan
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.
Science (New York, N.Y.) · 2024 · 202 citations · Alexander Huang
Nociceptor neurons affect cancer immunosurveillance.
Nature · 2022 · 297 citations · Ronny Drapkin